Clinical Trials Related to Small Lymphocytic Lymphoma

Related studies linked through entity extraction aliases.

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Status: COMPLETED
Phase: PHASE2

Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Status: COMPLETED
Phase: PHASE1

Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Status: TERMINATED
Phase: PHASE2

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

Status: COMPLETED
Phase: PHASE3

Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia

Status: COMPLETED
Phase: PHASE2

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Status: COMPLETED
Phase: PHASE2

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

Status: COMPLETED
Phase: PHASE2

Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Status: COMPLETED
Phase: PHASE2

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies

Status: COMPLETED
Phase: PHASE2

Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia

Status: TERMINATED
Phase: PHASE1

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Status: COMPLETED
Phase: PHASE2

Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Status: TERMINATED
Phase: PHASE2

Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia

Status: TERMINATED
Phase: PHASE1